These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35386234)

  • 1. Rapid Assessment of CRISPR Transfection Efficiency and Enrichment of CRISPR Induced Mutations Using a Dual-Fluorescent Stable Reporter System.
    Shalaby KE; Aouida M; Gupta V; Ghanem SS; El-Agnaf OMA
    Front Genome Ed; 2022; 4():854866. PubMed ID: 35386234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Modified Monomeric Red Fluorescent Protein Reporter for Assessing CRISPR Activity.
    Højland Knudsen C; Ásgrímsdóttir ES; Rahimi K; Gill KP; Frandsen S; Hvolbøl Buchholdt S; Chen M; Kjems J; Febbraro F; Denham M
    Front Cell Dev Biol; 2018; 6():54. PubMed ID: 29868584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic Improvement of CRISPR/Cas9 Editing in
    Ng H; Dean N
    mSphere; 2017; 2(2):. PubMed ID: 28435892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair.
    Wen Y; Liao G; Pritchard T; Zhao TT; Connelly JP; Pruett-Miller SM; Blanc V; Davidson NO; Madison BB
    J Biol Chem; 2017 Apr; 292(15):6148-6162. PubMed ID: 28228480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells.
    Moradi P; Hasanzadeh A; Radmanesh F; Rajai Daryasarei S; Hosseini ES; Kiani J; Shahbazi A; Nourizadeh H; Eslami M; Dorgalaleh A; Sahlolbei M; Hamblin MR; Karimi M
    Nanotechnology; 2021 Nov; 33(7):. PubMed ID: 34727527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts.
    Petersen BL; Möller SR; Mravec J; Jørgensen B; Christensen M; Liu Y; Wandall HH; Bennett EP; Yang Z
    BMC Biotechnol; 2019 Jun; 19(1):36. PubMed ID: 31208390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (
    Shen Y; Cohen JL; Nicoloro SM; Kelly M; Yenilmez B; Henriques F; Tsagkaraki E; Edwards YJK; Hu X; Friedline RH; Kim JK; Czech MP
    J Biol Chem; 2018 Nov; 293(44):17291-17305. PubMed ID: 30190322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.
    Montagna C; Petris G; Casini A; Maule G; Franceschini GM; Zanella I; Conti L; Arnoldi F; Burrone OR; Zentilin L; Zacchigna S; Giacca M; Cereseto A
    Mol Ther Nucleic Acids; 2018 Sep; 12():453-462. PubMed ID: 30195783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
    Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
    Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles ("Nanoblades").
    Mangeot PE; Guiguettaz L; Sohier TJM; Ricci EP
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33871447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient genome editing using endogenous U6 snRNA promoter-driven CRISPR/Cas9 sgRNA in Sclerotinia sclerotiorum.
    Wang C; Rollins JA
    Fungal Genet Biol; 2021 Sep; 154():103598. PubMed ID: 34119663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ribonucleoprotein transfection strategy for CRISPR/Cas9-mediated gene editing and single cell cloning in rainbow trout cells.
    Zoppo M; Okoniewski N; Pantelyushin S; Vom Berg J; Schirmer K
    Cell Biosci; 2021 Jun; 11(1):103. PubMed ID: 34082820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 system in Plasmodium falciparum using the centromere plasmid.
    Payungwoung T; Shinzawa N; Hino A; Nishi T; Murata Y; Yuda M; Iwanaga S
    Parasitol Int; 2018 Oct; 67(5):605-608. PubMed ID: 29886342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy.
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33690264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(Beta-Amino Ester) Nanoparticles Enable Nonviral Delivery of CRISPR-Cas9 Plasmids for Gene Knockout and Gene Deletion.
    Rui Y; Varanasi M; Mendes S; Yamagata HM; Wilson DR; Green JJ
    Mol Ther Nucleic Acids; 2020 Jun; 20():661-672. PubMed ID: 32380416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.